Mainz Biomed N.V.Mainz Biomed N.V.Mainz Biomed N.V.

Mainz Biomed N.V.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪10.46 M‬USD
−1.6393USD
‪−26.30 M‬USD
‪895.48 K‬USD
‪17.15 M‬
Beta (1Y)
0.86

About Mainz Biomed N.V.

CEO
Guido Baechler
Headquarters
Mainz
Founded
2021
ISIN
NL0015000LC2
FIGI
BBG012XZKGW7
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MYNZ is 0.4778 USD — it has increased by 3.11% in the past 24 hours. Watch Mainz Biomed N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mainz Biomed N.V. stocks are traded under the ticker MYNZ.
MYNZ stock has risen by 29.14% compared to the previous week, the month change is a 26.49% fall, over the last year Mainz Biomed N.V. has showed a 89.61% decrease.
We've gathered analysts' opinions on Mainz Biomed N.V. future price: according to them, MYNZ price has a max estimate of 4.00 USD and a min estimate of 2.00 USD. Watch MYNZ chart and read a more detailed Mainz Biomed N.V. stock forecast: see what analysts think of Mainz Biomed N.V. and suggest that you do with its stocks.
MYNZ reached its all-time high on Jan 18, 2022 with the price of 30.0000 USD, and its all-time low was 0.3150 USD and was reached on Jul 1, 2024. View more price dynamics on MYNZ chart.
See other stocks reaching their highest and lowest prices.
MYNZ stock is 18.12% volatile and has beta coefficient of 0.86. Track Mainz Biomed N.V. stock price on the chart and check out the list of the most volatile stocks — is Mainz Biomed N.V. there?
Today Mainz Biomed N.V. has the market capitalization of ‪10.46 M‬, it has increased by 4.54% over the last week.
Yes, you can track Mainz Biomed N.V. financials in yearly and quarterly reports right on TradingView.
Mainz Biomed N.V. is going to release the next earnings report on Sep 4, 2024. Keep track of upcoming events with our Earnings Calendar.
MYNZ earnings for the last quarter are −0.31 USD per share, whereas the estimation was −0.22 USD resulting in a −44.19% surprise. The estimated earnings for the next quarter are −0.20 USD per share. See more details about Mainz Biomed N.V. earnings.
Mainz Biomed N.V. revenue for the last quarter amounts to ‪250.00 K‬ USD, despite the estimated figure of ‪318.00 K‬ USD. In the next quarter, revenue is expected to reach ‪333.33 K‬ USD.
MYNZ net income for the last quarter is ‪−5.18 M‬ USD, while the quarter before that showed ‪−6.30 M‬ USD of net income which accounts for 17.72% change. Track more Mainz Biomed N.V. financial stats to get the full picture.
No, MYNZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mainz Biomed N.V. EBITDA is ‪−25.48 M‬ USD, and current EBITDA margin is ‪−2.86 K‬%. See more stats in Mainz Biomed N.V. financial statements.
Like other stocks, MYNZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mainz Biomed N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mainz Biomed N.V. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mainz Biomed N.V. stock shows the sell signal. See more of Mainz Biomed N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.